References

[Yaghoubi, 2020]

Mohsen Yaghoubi, Amin Adibi, Zafar Zafari, J. Mark FitzGerald, Shawn D. Aaron, Kate M. Johnson, and Mohsen Sadatsafavi. Cost-effectiveness of implementing objective diagnostic verification of asthma in the united states. Journal of Allergy and Clinical Immunology, 145(5):1367–1377.e4, 2020. URL: https://www.sciencedirect.com/science/article/pii/S0091674919316343, doi:https://doi.org/10.1016/j.jaci.2019.11.038.

[Einarson, 2015]

Thomas R. Einarson, Basil G. Bereza, T. Anders Nielsen, and Michiel E. H. Hemels. Utilities for asthma and copd according to category of severity: a comprehensive literature review and meta-analysis. Journal of Medical Economics, 18:550–563, 3 2015. URL: https://doi.org/10.3111/13696998.2015.1025793, doi:10.3111/13696998.2015.1025793.

[Kannisto, 1994]

Väinö Kannisto, Roger Thatcher, and James W. Vaupel. The force of mortality at ages 80 to 120. Monographs on Population Aging, 1994. URL: https://www.demogr.mpg.de/Papers/Books/Monograph5/start.htm.

[Mamun, 2019]

A. Mamun, B. Zhao, M. McCabe, and et al. Cost-benefit analysis of a population-based education program on the wise use of antibiotics. Can J Public Health, 110:732–740, 2019. URL: https://doi.org/10.17269/s41997-019-00245-w, doi:10.17269/s41997-019-00245-w.

[Patrick, 2020]

David M Patrick, Hind Sbihi, Darlene L Y Dai, Abdullah Al Mamun, Drona Rasali, Caren Rose, Fawziah Marra, Rozlyn C T Boutin, Charisse Petersen, Leah T Stiemsma, Geoffrey L Winsor, Fiona S L Brinkman, Anita L Kozyrskyj, Meghan B Azad, Allan B Becker, Piush J Mandhane, Theo J Moraes, Malcolm R Sears, Padmaja Subbarao, B Brett Finlay, and Stuart E Turvey. Decreasing antibiotic use, the gut microbiota, and asthma incidence in children: evidence from population-based and prospective cohort studies. The Lancet Respiratory Medicine, 8(11):1094–1105, 11 2020. URL: https://doi.org/10.1016/S2213-2600(20)30052-7, doi:10.1016/S2213-2600(20)30052-7.

[Lee, 2024]

Tae Yoon Lee, John Petkau, Ariana Saatchi, Fawziah Marra, Stuart E. Turvey, Hannah Lishman, David M. Patrick, Jacquelyn J. Cragg, Kate M. Johnson, and Mohsen Sadatsafavi. Impact analysis of infant antibiotic exposure on the burden of asthma: a simulation modeling study. Frontiers in Allergy, 2024. URL: https://www.frontiersin.org/journals/allergy/articles/10.3389/falgy.2024.1491985, doi:10.3389/falgy.2024.1491985.

[C., 2006]

Di Pietrantonj C. Four-fold table cell frequencies imputation in meta analysis. Statistics in Medicine, 25:2299–2322, 7 2006. doi:10.1002/sim.2287.

[Lee, 2026]

Tae Yoon Lee, John Petkau, Kate M. Johnson, Stuart E. Turvey, Amin Adibi, Padmaja Subbarao, Ainsleigh Hill, Mark Ewert, and Mohsen Sadatsafavi. Development of an asthma policy model for canada: lifetime exposures and asthma outcomes projection. PLOS One, 21(5):e0348878, 2026. URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0348878, doi:10.1371/journal.pone.0348878.

[{Global Initiative for Asthma}, 2023]

Global Initiative for Asthma. Global strategy for asthma management and prevention. 2023. Updated 2023. URL: https://www.ginasthma.org/reports.

[Lee, 2022]

Tae Yoon Lee, John Petkau, and Mohsen Sadatsafavi. Long-term natural history of severe asthma exacerbations and their impact on the disease course. Annals of the American Thoracic Society, 19(6):907–915, 2022. URL: https://doi.org/10.1513/AnnalsATS.202012-1562OC, doi:10.1513/AnnalsATS.202012-1562OC.

[Yan, 2024]

Jiajun Yan, Shitong Xie, Jeffrey A. Johnson, Eleanor Pullenayegum, Arto Ohinmaa, Bryan Stirling, and Feng Xie. Canada population norms for the eq-5d-5l. The European Journal of Health Economics, 25:147–155, 2 2024. URL: https://doi.org/10.1007/s10198-023-01570-1, doi:10.1007/s10198-023-01570-1.

[Lloyd, 2007]

A. Lloyd, D. Price, and R. Brown. The impact of asthma exacerbations on health-related quality of life in moderate to severe asthma patients in the uk. Primary Care Respiratory Journal, 16(1):22–27, 2007. URL: https://doi.org/10.3132/pcrj.2007.00002, doi:10.3132/pcrj.2007.00002.

[Campbell, 2010]

J. D. Campbell, D. E. Spackman, and S. D. Sullivan. The costs and consequences of omalizumab in uncontrolled asthma from a usa payer perspective. Allergy, 65(9):1141–1148, 2010. URL: https://doi.org/10.1111/j.1398-9995.2010.02336.x, doi:10.1111/j.1398-9995.2010.02336.x.

[Aldington, 2007]

S. Aldington and R. Beasley. Asthma exacerbations. 5: assessment and management of severe asthma in adults in hospital. Thorax, 62(5):447–458, 2007. URL: https://doi.org/10.1136/thx.2005.045203, doi:10.1136/thx.2005.045203.

[McTaggart-Cowan, 2008]

H. M. McTaggart-Cowan, P. Shi, J. M. Fitzgerald, A. H. Anis, J. A. Kopec, T. R. Bai, and others. An evaluation of patients' willingness to trade symptom-free days for asthma-related treatment risks: a discrete choice experiment. Journal of Asthma, 45(8):630–638, 2008. URL: https://doi.org/10.1080/02770900802126990, doi:10.1080/02770900802126990.

[Xie, 2022]

Yuanyu Xie, Meiyun Lin, Bertrand Decharme, Christine Delire, Larry W. Horowitz, David M. Lawrence, Fang Li, and Roland Séférian. Tripling of western us particulate pollution from wildfires in a warming climate. Proceedings of the National Academy of Sciences, 2022. URL: https://doi.org/10.1073/pnas.2111372119, doi:10.1073/pnas.2111372119.

[Bonett, 2007]

D. G. Bonett. Transforming odds ratios into correlations for meta-analytic research. American Psychologist, 62:254–255, 2007. URL: https://doi.org/10.1037/0003-066x.62.3.254, doi:10.1037/0003-066x.62.3.254.